In vitro evidence for complex modes of nuclear β-catenin signaling during prostate growth and tumorigenesis - Oncogene
Clicks: 231
ID: 273224
2002
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Star Article
30.0
/100
231 views
24 readers
AI Quality Assessment
Not analyzed
Readership in this journal
StarRanked #45 of 239 articles by views in Oncogene
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 239 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Understanding the molecular etiology of prostate cancer (CaP) progression is paramount for broadening current diagnostic and therapeutic modalities. Current interest in the role of wnt pathway signaling in prostate tumorigenesis was generated with the finding of β-catenin mutation and corresponding nuclear localization in primary lesions. The recent finding of β-catenin-induced enhancement of androgen receptor (AR) function potentially ties β-catenin to key regulatory steps of prostate cell growth, differentiation, and transformation. By immunohistological analysis of metastatic tumors, we detected nuclear β-catenin in 20% of lethal CaP cases, suggesting a more common role for β-catenin in advanced disease than would be predicted by its mutation rate. Interestingly, β-catenin nuclear localization was found to occur concomitantly with androgen-induced regrowth of normal rat prostate. These in vivo observations likely implicate β-catenin involvement in both normal and neoplastic prostate physiology, thus prompting our interest in further characterizing modes of β-catenin signaling in prostate cells. Extending our previous findings, we demonstrate that transient β-catenin over-expression stimulates T cell factor (TCF) signaling in most CaP cell lines. Further, this activity is not subject to cross-regulation by phosphoinositide-3-kinase (PI3-K)/Akt signaling, a stimulatory pathway often upregulated in CaP upon PTEN inactivation. Consistent with a previous report, we observed that transient β-catenin over-expression enhances AR-mediated transcription off two natural target gene promoters. However, we were unable to recapitulate β-catenin-induced stimulation of ectopically expressed AR in AR-negative cells, suggesting that other AR-associated factors are required for this activity. Although LNCaP cells are capable of this mode of AR co-stimulation, stable expression of mutant β-catenin did not alter their proliferative response to androgen. In total, our characterization of β-catenin signaling in CaP reveals the complex nature of its activity in prostate tissue, indicating that β-catenin potentially contributes to multiple stimulatory inputs required for disease progression.
| Reference Key |
r2002oncogenein
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Chesire, Dennis R;Ewing, Charles M;Gage, Wesley R;Isaacs, William B;Chesire, Dennis R;Ewing, Charles M;Gage, Wesley R;Isaacs, William B; |
| Journal | Oncogene |
| Year | 2002 |
| DOI |
doi:10.1038/sj.onc.1205352
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.